DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $874,404 | +2.9% | 3,524 | -0.4% | 0.04% | +5.6% |
| Q2 2023 | $849,410 | -0.8% | 3,539 | +4.2% | 0.04% | -7.7% |
| Q1 2023 | $856,178 | +44010.1% | 3,397 | -53.5% | 0.04% | -25.0% |
| Q4 2022 | $1,941 | -99.8% | 7,312 | +98.2% | 0.05% | -18.8% |
| Q3 2022 | $953,000 | +109.5% | 3,689 | +105.7% | 0.06% | +88.2% |
| Q2 2022 | $455,000 | -54.8% | 1,793 | -47.8% | 0.03% | -38.2% |
| Q1 2022 | $1,007,000 | -41.7% | 3,434 | -34.6% | 0.06% | -36.8% |
| Q4 2021 | $1,727,000 | +6.0% | 5,248 | -1.9% | 0.09% | -3.3% |
| Q3 2021 | $1,629,000 | -4.2% | 5,350 | -15.6% | 0.09% | -4.3% |
| Q2 2021 | $1,701,000 | +6.6% | 6,337 | -10.7% | 0.09% | -1.1% |
| Q1 2021 | $1,596,000 | +7.8% | 7,093 | +6.4% | 0.10% | +4.4% |
| Q4 2020 | $1,480,000 | -1.3% | 6,664 | -4.3% | 0.09% | -15.0% |
| Q3 2020 | $1,500,000 | +26.7% | 6,964 | +4.0% | 0.11% | +21.6% |
| Q2 2020 | $1,184,000 | +32.1% | 6,693 | +3.4% | 0.09% | +1.1% |
| Q1 2020 | $896,000 | -5.2% | 6,475 | +5.2% | 0.09% | +6.1% |
| Q4 2019 | $945,000 | +8.4% | 6,154 | +1.9% | 0.08% | -1.2% |
| Q3 2019 | $872,000 | +10.0% | 6,040 | +8.9% | 0.08% | +7.8% |
| Q2 2019 | $793,000 | -8.4% | 5,547 | -15.4% | 0.08% | -10.5% |
| Q1 2019 | $866,000 | +27.5% | 6,556 | -0.5% | 0.09% | +10.3% |
| Q4 2018 | $679,000 | -0.7% | 6,589 | +4.7% | 0.08% | +1.3% |
| Q3 2018 | $684,000 | +11.4% | 6,296 | +1.1% | 0.08% | +8.5% |
| Q2 2018 | $614,000 | +1.5% | 6,225 | +0.8% | 0.07% | -6.6% |
| Q1 2018 | $605,000 | +7.7% | 6,177 | +2.0% | 0.08% | +15.2% |
| Q4 2017 | $562,000 | +16.1% | 6,058 | +7.5% | 0.07% | -9.6% |
| Q3 2017 | $484,000 | -10.9% | 5,637 | -12.3% | 0.07% | -16.1% |
| Q2 2017 | $543,000 | -1.3% | 6,429 | 0.0% | 0.09% | -6.5% |
| Q1 2017 | $550,000 | +25.9% | 6,429 | +14.5% | 0.09% | +17.7% |
| Q4 2016 | $437,000 | -5.8% | 5,615 | -5.1% | 0.08% | -14.1% |
| Q3 2016 | $464,000 | -22.8% | 5,918 | -0.6% | 0.09% | -28.7% |
| Q2 2016 | $601,000 | +4.5% | 5,953 | -1.8% | 0.13% | -4.4% |
| Q1 2016 | $575,000 | +15.7% | 6,061 | +13.2% | 0.14% | +3.8% |
| Q4 2015 | $497,000 | -5.3% | 5,352 | -13.1% | 0.13% | -23.5% |
| Q3 2015 | $525,000 | -5.6% | 6,159 | -5.1% | 0.17% | -10.1% |
| Q2 2015 | $556,000 | -3.1% | 6,491 | -4.0% | 0.19% | -3.6% |
| Q1 2015 | $574,000 | -0.7% | 6,764 | +0.2% | 0.20% | -1.5% |
| Q4 2014 | $578,000 | -2.4% | 6,749 | -13.4% | 0.20% | -7.0% |
| Q3 2014 | $592,000 | +0.3% | 7,794 | +3.9% | 0.21% | +4.4% |
| Q2 2014 | $590,000 | +5.0% | 7,498 | 0.0% | 0.20% | 0.0% |
| Q1 2014 | $562,000 | +54.4% | 7,498 | +58.9% | 0.20% | +56.5% |
| Q4 2013 | $364,000 | +11.3% | 4,719 | 0.0% | 0.13% | -3.0% |
| Q3 2013 | $327,000 | -45.3% | 4,719 | -50.0% | 0.14% | +4.7% |
| Q2 2013 | $598,000 | – | 9,438 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |